Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Clinical trial NCT07708727 · RECRUITING
Trial details
- NCT number
- NCT07708727
- Sponsor
- Gilead Sciences
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-29
- Primary completion
- 2030-10-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.